Avacta and Pall expand analytical service
This article was originally published in Scrip
Executive Summary
UK pharmaceutical and diagnostic services firm Avacta is expanding its relationship with US filtration, separation and purification specialist Pall to provide analytical services to pharma companies, particularly in North America, which the partners say can reduce the costs of drug discovery. The service includes screening molecules and optimising manufacturing and purification conditions. The services will be delivered through Pall's Scientific Laboratories Services global network, and Avacta's lab in York, UK. Financial details of the deal were not disclosed.